Beneficient (NASDAQ:BENF) Stock Short Interest Report for October

Beneficient (NASDAQ:BENF) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 516,945 shares, a decline of 45.6% from the September 30th total of 950,383 shares. Currently, 12.8% of the company’s shares are sold short. Based on an average daily trading volume, of 1,150,374 shares, the short-interest ratio is presently 0.4 days.

Beneficient Stock Performance

NASDAQ:BENF traded down $0.07 during mid-day trading on Friday, hitting $0.73. The company had a trading volume of 266,591 shares, compared to its average volume of 643,123. Beneficient has a fifty-two week low of $0.50 and a fifty-two week high of $9.96. The business’s fifty day moving average is $1.33 and its two-hundred day moving average is $3.05. The firm has a market cap of $11.35 million, a P/E ratio of -0.10 and a beta of -0.01.

Beneficient (NASDAQ:BENF) last posted its earnings results on Friday, August 14th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.06) by $1.59. The company had revenue of $15.93 million for the quarter, compared to analyst estimates of $10.16 million. Equities analysts forecast that Beneficient will post -9.50 earnings per share for the current year.

Institutional Investors Weigh In On Beneficient

An institutional investor recently bought a new stake in Beneficient stock. T3 Companies LLC bought a new position in shares of Beneficient (NASDAQ:BENF) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 43,030 shares of the company’s stock, valued at approximately $59,000. T3 Companies LLC owned approximately 0.28% of Beneficient at the end of the most recent quarter. Institutional investors own 90.57% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on BENF shares. Wall Street Zen raised shares of Beneficient to a “hold” rating in a research note on Saturday, October 24th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beneficient in a report on Monday, September 21st. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Beneficient presently has an average rating of “Sell”.

Beneficient Company Profile

Beneficient (NASDAQ: BENF) is a financial services company that provides liquidity and trust solutions for holders of alternative assets. Its platform is designed to help investors access liquidity from interests in private equity, venture capital, private credit, real estate and other illiquid investments without relying solely on traditional secondary-market sales.

The company’s offerings include the ExAlt Plan, which is structured to allow eligible investors to contribute alternative assets to trusts in exchange for interests that may provide access to liquidity, and AltQuote, a technology-enabled service intended to help investors evaluate potential liquidity options for their holdings.